Dr. Ethan Russo talks about the “Farmacology, toxicology and therapeutic potential of cannabis” and what “Endocannabinoid system deficiency” is. Both presentations are with Spanish subtitles in the video below, also with the Q&A session.

Dr. Ethan Russo
Neurologist and researcher in psychopharmacology, former medical advisor of GW Pharmaceuticals cannabis-based drug developer laboratory. He participated in three Phase III clinical trials for the approval of Sativex, a cannabis-based drug for the treatment of multiple sclerosis. Former President of the International Association for Cannabis as a Medication and current Medical Director of Phytecs. Author of several books and scientific articles related to medicinal cannabis.